Abstract:Two distinct lipoprotein receptors can be expressed in the dog liver. One is the apolipoprotein (apo-) B,E receptor. This receptor binds apo-B-containing low density lipoproteins (LDL), as well as apo-E-containing lipoproteins, such as the cholesterol-induced high density lipoproteins (HDL(c)). The second hepatic lipoprotein receptor is the apo-E receptor. It binds apo-E HDL(c) and chylomicron remnants, but not LDL. The present studies were undertaken to determine whether short-term (acute) regulation of the two receptors can occur in response to perturbations in hepatic cholesterol metabolism. The design used three groups of experimental animals: (a) immature dogs (with both hepatic apo-B,E and apo-E receptors expressed), (b) adult dogs (with predominantly the apo-E receptor expressed and little detectable apo-B,E receptor binding activity), and (c) dogs treated with the bile acid sequestrant cholestyramine or those that have undergone biliary diversion (with apo-E receptors and induced apo-B,E receptors). In the first series of experiments, changes in hepatic lipoprotein receptor expression were studied by delivering cholesterol to the liver via intestinal lymph lipoproteins. Dog lymph (5-11 mg of triglycerides/min per kg of body weight, 0.15-0.3 mg of cholesterol/min per kg) or saline were infused intravenously for 6-8 h into matched pairs of dogs. Serial liver biopsies were obtained at intervals of 1-2 h. A progressive loss of specific (calcium-dependent) binding of LDL was seen in hepatic membranes from both immature and cholestyramine-treated dogs. After 4-6 h of lymph infusion, almost no apo-B,E receptor binding could be detected. The decrease in binding of apo-E HDL(c) to the same membranes was much less pronounced, and could be explained by a loss of binding of HDL(c) to the apo-B,E receptor; there was little or no effect on apo-E receptor binding. In the second series of experiments, the effects of a diminished hepatic demand for cholesterol on lipoprotein receptor expression were studied by suppressing bile acid synthesis. The bile acid taurocholate (2-3 mumol/kg per min) was infused intravenously over a 6-h interval. This resulted in a progressive loss of LDL binding to liver membranes of immature or cholestyramine-treated dogs. The infusion of taurocholate for 6 h did not significantly alter the expression of the apo-E receptor binding activity, whereas apo-B,E receptor activity was rapidly down-regulated. Preparation of a bile fistula in adult dogs markedly induced the expression of the apo-B,E receptor. In this state, the binding activity of the apo-B,E receptor could be almost totally abolished by reinfusion of taurocholate for 6 h, without profoundly affecting apo-E receptor binding. Evidence from the analysis of plasma lipoprotein patterns and tissue culture reactivity suggested that changes in assayed hepatic lipoprotein receptor activity occurred in concert with changes in plasma lipoproteins.The results indicate that the two canine hepatic lipoprotein receptors differ in their metabolic regulation. The apo-B,E receptor responds rapidly to changes in hepatic requirements for cholesterol. The apo-E receptor appears to be more refractory to acute regulation. The rapidity of the changes in the activity of the apo-B,E receptor (within 2-4 h) suggests that the binding activity of this receptor may be regulated by factors independent of protein synthesis.

Studies on Very Low Density Lipoprotein Receptor in Animal

Comparative-Studies on Liquid-Crystal Lipoid Droplets of Livers from Newborn Birds (Domestic-Fowl)

Receptor-mediated low-density lipoprotein catabolism

High density lipoprotein metabolism in low density lipoprotein receptor-deficient mice

A Lipidomics Study Reveals Hepatic Lipid Signatures Associating with Deficiency of the LDL Receptor in a Rat Model.

Selective and Regenerable Surface Based on Β-Cyclodextrin for Low-Density Lipoprotein Adsorption

The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor

Effects and mechanisms of apolipoprotein A-V on the regulation of lipid accumulation in cardiomyocytes

Receptors and Lipid Transfer Proteins in HDL Metabolism

Recent advances in physiological lipoprotein metabolism

Post-translational regulation of the low-density lipoprotein receptor provides new targets for cholesterol regulation

1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis.

Rab2A-mediated Golgi-lipid Droplet Interactions Support Very-Low-density Lipoprotein Secretion in Hepatocytes

Lipoprotein Lipase and Its Regulators: an Unfolding Story.

Lipid Transfer Proteins HDL Metabolism and Atherogenesis

1999 George Lyman Duff Memorial Lecture

Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids

Proteomic Studies Of Isolated Lipid Droplets From Bacteria, C-Elegans, And Mammals

Lipoprotein (a):A Vital Member of Blood Lipid Items

A High-Density-lipoprotein Receptor Appears to Mediate the Transfer of Essential Fatty Acids from High-Density Lipoprotein to Lymphocytes

VLDL Biogenesis and Secretion: It Takes a Village